Wiping Out Gut Bugs Stops Obesity

In mice lacking intestinal microbiota, white fat turns brown and obesity is prevented.

Written byKerry Grens
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

FLICKR, NIAIDThe gut microbiome is typically considered essential for proper health, but a study in mice shows that, at least when it comes to insulin sensitivity and obesity, that may not be the case. In Nature Medicine today (November 16), researchers reported that animals without intestinal microbiota had better glucose tolerance and insulin sensitivity, less white fat, and lower body mass.

“Although treating obesity with high doses of antibiotics is unrealistic—mainly due to the risk of antibiotic resistance—we want to explore alternative ways of suppressing or modifying the microbiota, and to identify the exact bacterial genes responsible for this phenomenon,” Mirko Trajkovski of the University of Geneva said in a statement. “We would then target only those, without having to deplete the entire microbiota.”

Trajkovski and his colleagues put mice on a high-fat diet after either erasing their microbiome with antibiotics or raising them in a germ-free environment. While normal mice became obese, the microbe-free mice remained lean and produced more beige fat, an energy-burning form of adipose tissue.

The germ-free mice also had higher levels of certain cytokines. “Inhibition of this signaling impairs antibiotic-induced subcutaneous-fat ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies